Clyde R. Morron III, PA

Clyde Morron practices at Epiphany Dermatology PA in Austin, Texas.

Clyde Morron's NPI, 1356352298, was assigned on August 9, 2006. Clyde Morron holds Texas license PA04181.

Clyde Morron's primary practice is Epiphany Dermatology PA, at 7300 Ranch Rd 2222, Austin, TX 78730 in Travis County. The practice phone is (254) 537-1265.

Clyde Morron's primary practice is Epiphany Dermatology PA in Austin, Texas. The medical group on file is Epiphany Dermatology. Dmand AI also links Clyde Morron to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Clyde Morron practices. Vendor and product names are available with a free account.

Physician assistant is Clyde Morron's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Clyde Morron is licensed in Texas.

Dmand AI lists acne, acute skin infection, ankle or foot injury, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, head wound and hives among the conditions Clyde Morron treats.

CMS data shows 1,141 Medicare services from Clyde Morron across 13 procedure codes in 2024, for 440 Medicare patients. Medicare paid $48,248 for them. Every service was in an office.

CMS counts 440 Medicare patients who saw Clyde Morron in 2024. The largest group is 65 to 74, with 218 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.05, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Clyde Morron's median patient age at 61, with 53% women.

In 2024, Clyde Morron wrote 1,724 Medicare Part D claims for 586 patients. 96% of them were for generic drugs. CMS names the drug for 1,516 of them, across 23 drugs with 11 or more claims each, at $232,545 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Clyde Morron for performance year 2024, reported as part of a group. Clyde Morron accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 180 general payments to Clyde Morron from 22 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 93% of the total. Incyte Corporation paid the most, $706.